Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Pierre Fabre obtains good results with RSV subunit vaccine in monkey model

Sep. 24, 1998

Cangene signs WinRho distribution agreement for Australia

Sep. 24, 1998

Vertex issued first U.S. patent for IMPDH inhibitors, begins phase II trials of lead inhibitor

Sep. 23, 1998

International team reports discovery of novel immunostimulants

Sep. 21, 1998

MedImmune and Chiron enter agreement on vaccine adjuvant technology

Sep. 21, 1998

Cangene files for German approval of next-generation WinRho product

Sep. 18, 1998

DNA immunization against rabies effectively protects nonhuman primates

Sep. 17, 1998

Aviron's FluMist PLA/ELA deemed nonfilable by FDA; resubmission planned

Sep. 15, 1998

New T-cell kinase inhibitor presented by Abbott at ACS meeting

Sep. 10, 1998

Potent and selective inhibitors of p56lck kinase developed at Celltech

Sep. 9, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...